Bulk-tissue RNA-Seq is seeing increasing use in the study of physiological and pathophysiological processes in the kidney. However, the presence of multiple cell types in kidney complicates the data interpretation. Here we address the question, "What cell types are represented in whole-kidney RNA-Seq data?" to identify circumstances in which bulk-kidney RNA-Seq can be successfully interpreted. We carried out RNA-Seq in mouse whole kidneys and microdissected renal tubule segments. To aid in the interpretation of the data, we compiled a database of cell-type selective protein markers for 43 cell types believed to be present in kidney tissue. The whole-kidney RNA-Seq analysis identified transcripts corresponding to 17742 genes, distributed over 5 orders of magnitude of expression level. Markers for all 43 curated cell types were detectable. Analysis of the cellular makeup of mouse and rat kidney, calculated from published literature, suggests that proximal tubule cells account for more than half of the mRNA in a kidney. Comparison of RNA-Seq data from microdissected proximal tubules with wholekidney data supports this view. RNA-Seq data for cell-type selective markers in bulk-kidney samples provide a valid means to identify changes in minority-cell abundances in kidney tissue.
INTRODUCTION
RNA-Seq is a method for identifying and quantifying all mRNA species (considered in this paper) in a sample as well as many non-coding RNA species. 1, 2, 3 Like RT-PCR, the first step of RNA-Seq is reverse transcription of all mRNAs to give corresponding cDNAs. However, unlike RT-PCR, which amplifies only one cDNA target, RNA-Seq amplifies all cDNAs in the sample through use of adaptors that are ligated to the ends of each cDNA. 4 The read-out for RNA-Seq employs next-generation DNA sequencers to identify specific sequences that map to each mRNA transcript coded by the genome of a particular species (the 'transcriptome'). This allows counting of the number of 'reads' for each transcript as a measure of the total amount of each transcript in the original sample. So, RNA-Seq can be viewed simplistically like quantitative RT-PCR, but more expansive and unbiased. 1 The abundance of a given transcript is assumed to be proportional to the number of independent sequence 'reads' normalized to the annotated exon length of each individual gene and to the total reads obtained for a sample. This calculation yields transcripts per million or 'TPM' as termed in this paper. 5 RNA-Seq has seen increased use in recent years, in part because of the ease of execution and the availability of next-generation DNA sequencers. 6 Because of the existence of private-sector biotechnology companies, even small laboratories can successfully carry out RNA-Seq studies in lieu of quantitative RT-PCR. Many recent reports using RNA-Seq employ "bulk-tissue RNA-Seq" in which complex tissues containing multiple cell types are analyzed. The limitation of this approach is that it is usually impossible to determine which cell types in the mixture are responsible for observed changes in mRNA abundances. Furthermore, strong responses in minority cell types may be masked by a lack of response in more abundant cell types. 7 Similar limitations apply to other analytical modalities, such as proteomics.
A solution to this problem in kidney is to isolate specific cell types using renal tubule micro-dissection prior to small sample RNA-Seq as described by Lee et al. 8, 9 All 14 renal tubule segments plus glomeruli have been profiled in this way. In structures that contain more than one 4 cell type, transcriptomes of each cell type can be determined using single-cell RNA seq (scRNA-Seq). 10, 11, 12, 13, 14, 15, 16, 17 However, RNA-Seq in single tubules or single cells is not always feasible, e.g. in pathophysiological models or biopsy samples when inflammation or fibrosis limits tissue dissection or single-cell dissociation. In this context, we ask the question, "Despite the existence of multiple cell types in bulk-kidney samples, what information about specific cell types can be gleaned from whole-kidney RNA-Seq?"
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RESULTS
What mRNA species are detectable in whole-kidney RNA-Seq analysis?
We carried out RNA-Seq analysis in three whole-kidney samples from untreated 2-month-old male C57BL/6
mice. Supplemental Figure 1 shows that the percentage of uniquely mapped reads exceeded 85% of the total reads indicating high data quality for all three samples. Total reads for each of the three samples exceeded 66 million reads. Figure 1 shows the reads that mapped to selected genes expressed over a broad range of TPM levels. Mapping of whole kidney RNA-Seq reads on a genome browser can be viewed by clicking on "UCSC Genome Browser" at this site. Since the data in this paper were obtained exclusively from 2-month-old male C57BL/6 mice, the reader is cautioned about possible differences that may occur on the basis of gender, age, mouse strain, animal species, food intake, etc. Further studies will be needed to identify the effects of these variables. Tables 1 and 2 . Table 1 shows TPM values for selected markers of epithelial cell types and Table 2 shows TPM values for selected markers of non-epithelial cell types. As seen in Table 1 (Table 3) . 24 The number of podocytes per mouse kidney is smaller (about 75 per glomerulus). 25 This would give 20220 glomeruli per mouse kidney X 75 podocytes per glomerulus = 1.5 X 10 6 podocytes per mouse kidney. This comes out to 3.0% of total epithelial cells in mouse kidney ( The list of housekeeping genes was taken from Lee et al. 8 The ratios for all genes were normalized such that the average WK/S2 TPM ratio is 1 for housekeeping genes that have TPM greater than 1. A tight correlation was seen for housekeeping transcripts ( Figure 2A ). As expected, WK/S2 ratios varied over a broad range for nonhousekeeping transcripts. The lower bound is seen at a ratio of about 0.25 and coincides with the location of S2-specific transcripts, e.g. Slc22a7 and Slc22a13, which mediate organic anion and organic cation secretion, respectively, key functions of the S2 segment. 27 This suggests that the S2 segment accounts for approximately one quarter of whole kidney mRNA. Kap, a proximal tubule marker expressed in all three subsegments (S1, S2, and S3) is found near the 0.5 ratio line, suggesting that the proximal tubule may account for roughly 50% of whole kidney mRNA.
TPM values for microdissected mouse cortical thick ascending limbs (cTALs) and cortical collecting ducts (CCDs) were mined from a prior study 10 
What is the contribution of non-epithelial cell types to the overall bulk kidney
transcriptome? Given the estimates of the percent contribution of each epithelial cell type in 9   Table 3 and RNA-Seq data from microdissected tubules from rat kidney, 8 it is possible to calculate a 'reconstructed' bulk kidney transcriptome. This can be compared to rat whole-kidney RNA-Seq data from our laboratory (Gene Expression Omnibus, number GSE70012). The difference between the two can be attributed to non-renal tubule cell types and is presented in Table 4 and Supplemental Dataset 5 in the form of measured:reconstructed ratios. As seen in Table 4 , this analysis in rat confirms the presence of several non-renal tubule cell types in bulk kidney tissue and establishes the listed markers as detectible in normal rat kidneys.
Reconstructed RNA-Seq transcriptome of whole kidney from scRNA-Seq data. Recently, there have been several reports that provide single-cell RNA-Seq data for many of the known renal tubule cell types. 10, 11, 12, 13, 14, 15, 16, 17 In theory, single-cell transcriptomes could be used to produce reconstructed bulk-kidney transcriptomes in a manner similar to that presented in the previous section using data from microdissected renal tubules. However, the calculation requires comprehensive transcriptomes in each cell, i.e. a full accounting of the abundances of all expressed transcripts, which appears to correspond to 7000-8000 expressed genes in each cell type. 8 Figure 3A shows the average number of transcripts quantified in selected individual cell types in a recent scRNA-Seq profiling study that used a state-of-the-art droplet-based method. 15 Similar values (not shown) were obtained from another recent droplet-based scRNASeq studies of kidney. 11 As can be seen, the average number of transcripts quantified was in the range 274-476. Thus, although the most abundant transcripts were found, the transcriptome list does not appear to be comprehensive despite the use of state-of-the-art methodology.
Furthermore, information about gene expression that can identify a particular cell type is conveyed only in nonhousekeeping genes, which constituted less than a third of the total. As shown in Figure 3B , RPKM or TPM values from comprehensive transcriptomic data sets shows that the percent nonhousekeeping transcripts increases beyond that obtained in droplet-based scRNA-Seq of kidney (shaded region). Thus, a goal for the future is to increase the depth of 10 scRNA-Seq transcriptomic analysis for all major cell types in the kidney. A strategy for doing this is proposed in the Discussion.
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In this paper, we asked the question, "What information about specific cell types can be 
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Our analysis of the abundances of individual epithelial cell types confirms that proximal tubule cells account for a large fraction of the total kidney substance, most likely at least 50%.
The S2 segment alone appears to account for approximately 25% of whole kidney mRNA ( Figure 2B ). This raises the question of whether whole kidney measurements suffice to assess changes in the proximal tubule. Clearly, changes in proximal tubule mRNA abundance for a particular gene should be detectable in whole kidney samples, although the magnitude of 12 changes will be attenuated by dilution by other cell types. The main problem with interpreting whole kidney changes as tantamount to changes in the proximal tubule is that large changes that are specific to other segments would also be manifest in whole kidney samples.
Furthermore, changes in the proximal tubule could be masked by opposite changes in other cell types. Consequently, we do not recommend using whole-kidney or bulk-tissue RNA-Seq as the sole methodology to address hypotheses about the proximal tubule. One approach that may be better in this setting is single-tubule RNA-Seq, 8 in which proximal tubules are first microdissected from the kidney and then subjected to small sample RNA-Seq analysis. In this paper, we present new single-tubule RNA-Seq data on the transcriptome of microdissected S2
proximal straight tubules and present a comparison with the whole-kidney RNA-Seq data.
The compendium of cell-type selective protein markers provided in this paper is a resource that may be useful to investigators. We caution that the list is not necessarily comprehensive. The list includes multiple markers that have been claimed for certain cell types, many of which were chosen because the protein is present on the cell surface allowing cell sorting. The imprecise definition of the term "cell marker" may lead to uncertainty when interpreting different types of data, thus cell surface markers could be suboptimal for interpretation of RNA-Seq data. Furthermore, many markers have been claimed to be cell-type specific in several cell types, contradicting the specificity claim. In general, we believe that there is a need for a kidney-community oriented effort to define the best cell markers for various uses.
In this paper, we have shown that it is possible to create a 'reconstructed' whole-kidney transcriptome from transcriptomes of individual renal tubule segments and information about the relative abundances of each cell type in the kidney from morphometric data. Success with this exercise has helped to validate the accuracy of quantitative RNA-Seq data from structures isolated from the kidney. This bodes well also for establishing the validity of scRNA-Seq measurements. 10, 11, 12, 13, 14, 15, 16, 17 However, we could not carry out whole-kidney reconstructions using the state-of-the-art scRNA-Seq data that is currently available because 13 the number of transcripts measured in these studies (274-476) fell short of the full depth of cellular transcriptomes (at least 7000-8000). 8 Thus, although the scRNA-Seq data that have been published represents a very large step forward, there remains an un-reached objective, viz. to push the method so that the scRNA-Seq identifies full transcriptomes for all of the major cell types. Until now, comprehensive scRNA-Seq studies have employed a shotgun approach which involved digestion of the whole kidney and sequencing to obtain transcriptomes for all single cells obtained. 11, 15 A limitation of this approach is that, as confirmed in this study, proximal tubule cells are much more abundant than any other cell type in the kidney.
Consequently, an unbiased sequencing of all cells results in most of the sequencing resources being devoted to proximal tubule cell transcriptomes. As a result, if investigators increase the amount of sequencing to obtain deeper transcriptomes with a shotgun approach, most of the additional effort will be wasted on proximal-tubule cells. To avoid this inefficiency, in the quest to obtain deep transcriptomes in minority cell types, it may be necessary to use microdissection, biochemical procedures, or flow sorting to isolate or enrich those cell types. Already, scRNASeq studies have been reported using this strategy for components of the glomerulus 12 and the collecting duct. 10 Beyond this reconstruction approach, there is potential value in being able to work in the opposite direction to 'deconvolute' bulk-tissue data, 29 e.g. in the analysis of formalin-fixed paraffin-embedded kidney biopsy samples, 30, 31 to ascertain what cell types are present in the samples and how they are altered by disease processes. This can succeed qualitatively by identifying cell-type specific transcripts that differ in abundance in a patient sample versus some appropriate reference. However, a difference in a particular transcript could be due either to a change in the number of cells or a change in the expression of the marker in each cell. The use of multiple markers may help to resolve this ambiguity. In the long term, machine learning techniques can be used to generate classifiers from bulk RNA-Seq data that can identify disease processes. Whole-kidney RNA-Seq and single-tubule RNA-Seq. These steps were conducted as previously reported. 10 Briefly, total RNA from whole kidney and microdissected proximal tubules were extracted using Direct-zol RNA MicroPrep kit (Zymo Research, Irvine, CA) and cDNA was generated by SMARTer V4 Ultra Low RNA kit (Clontech, Mountain View, CA) according to the manufacturer's protocols. 1 ng cDNA was fragmented and barcoded using Nextera XT DNA Sample Preparation Kit (Illumina, San Diego, CA). Libraries were generated by PCR amplification, purified by AmPure XP magnetic beads, and quantified using a Qubit 2.0
Fluorometer. Library size distribution was determined using an Agilent 2100 bioanalyzer with a High-Sensitive DNA Kit (Agilent, Wilmington, DE). Libraries were pooled and sequenced 16 (paired-end 50bp) on Illumina Hiseq 3000 platform to an average depth of 60 million reads per sample.
Data processing and transcript abundance quantification. Data processing was performed as previously reported. 10 Briefly, raw sequencing reads were processed by FASTQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and aligned by STAR 33 to the mouse Ensembl genome (Ensembl, GRCm38.p5) with Ensembl annotation (Mus_musculus.GRCm38.83.gtf). Unique genomic alignment was processed for alignment visualization on the UCSC Genome Browser. Transcript abundances were quantified using RSEM 5 in the units of transcripts per million (TPM). Unless otherwise specified, the calculations were done on the NIH Biowulf High-Performance Computing platform.
Whole kidney and proximal tubule transcriptomes. The mean TPM values were calculated across all samples: 3 mice, (whole kidney, n=3) and (S2 proximal tubule, n=12).
These filtered data are reported on specialized publicly accessible, permanent web pages to provide a community resource: https://hpcwebapps.cit.nih.gov/ESBL/Database/MusRNASeq/index.html.
Data deposition.
The FASTQ sequences and metadata reported in this paper have been deposited in NCBI's Gene Expression Omnibus (GEO) database, (accession number: GSE111837; https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE111837, secure token:
Curation of list of cell-type selective genes. To identify a list of cell-type selective genes from renal tubule segments, we used data from microdissected rat renal tubules published by Lee et al. 8 as well as data from mouse microdissected tubules and single cells described by
Chen et al. 10 and Park et al. 15 For other cell types, markers were determined using a combination of the following sources: general PubMed searches for publicly accessible research articles, commercial information sources for recommended marker antibodies, and general 
